BioNTech SE is 7.3x more valuable than Beam Therapeutics Inc. by market capitalization ($22.18 B vs $3.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BEAM | BNTX |
|---|---|---|
| Market cap | $3.03 B | $22.18 B |
| US-listed rank | #1807 | #582 |
| Revenue (latest FY) | $139.74M | - |
| Net income (latest FY) | -$79.99M | - |
| Net margin | -57.2% | - |
| SEC filings | 488 | 548 |
BioNTech SE is 7.3x more valuable than Beam Therapeutics Inc. by market capitalization ($22.18 B vs $3.03 B).
Full pages: Beam Therapeutics Inc. and BioNTech SE, or browse the full rankings.